nodes	percent_of_prediction	percent_of_DWPC	metapath
Telavancin—Venous thrombosis—Temsirolimus—kidney cancer	0.0457	0.0457	CcSEcCtD
Telavancin—Abscess—Temsirolimus—kidney cancer	0.0312	0.0312	CcSEcCtD
Telavancin—Extravasation—Temsirolimus—kidney cancer	0.0283	0.0283	CcSEcCtD
Telavancin—Extravasation—Vinblastine—kidney cancer	0.0211	0.0211	CcSEcCtD
Telavancin—Tenderness—Erlotinib—kidney cancer	0.0203	0.0203	CcSEcCtD
Telavancin—Abscess—Sunitinib—kidney cancer	0.0194	0.0194	CcSEcCtD
Telavancin—Venous thrombosis—Paclitaxel—kidney cancer	0.0191	0.0191	CcSEcCtD
Telavancin—Necrosis—Dactinomycin—kidney cancer	0.0185	0.0185	CcSEcCtD
Telavancin—Hyperkalaemia—Everolimus—kidney cancer	0.018	0.018	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Temsirolimus—kidney cancer	0.0179	0.0179	CcSEcCtD
Telavancin—Hyponatraemia—Pazopanib—kidney cancer	0.0169	0.0169	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Pazopanib—kidney cancer	0.0169	0.0169	CcSEcCtD
Telavancin—Extravasation—Dactinomycin—kidney cancer	0.0166	0.0166	CcSEcCtD
Telavancin—Venous thrombosis—Capecitabine—kidney cancer	0.0157	0.0157	CcSEcCtD
Telavancin—Phlebitis—Vinblastine—kidney cancer	0.0155	0.0155	CcSEcCtD
Telavancin—Ulcer—Dactinomycin—kidney cancer	0.0153	0.0153	CcSEcCtD
Telavancin—Hyperkalaemia—Sunitinib—kidney cancer	0.0151	0.0151	CcSEcCtD
Telavancin—Extravasation—Vincristine—kidney cancer	0.0149	0.0149	CcSEcCtD
Telavancin—Tenderness—Gemcitabine—kidney cancer	0.0141	0.0141	CcSEcCtD
Telavancin—Extravasation—Gemcitabine—kidney cancer	0.0141	0.0141	CcSEcCtD
Telavancin—Hyponatraemia—Everolimus—kidney cancer	0.0134	0.0134	CcSEcCtD
Telavancin—Necrosis—Paclitaxel—kidney cancer	0.0131	0.0131	CcSEcCtD
Telavancin—Ulcer—Gemcitabine—kidney cancer	0.013	0.013	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Erlotinib—kidney cancer	0.0129	0.0129	CcSEcCtD
Telavancin—Phlebitis—Dactinomycin—kidney cancer	0.0122	0.0122	CcSEcCtD
Telavancin—Tenderness—Paclitaxel—kidney cancer	0.0118	0.0118	CcSEcCtD
Telavancin—Extravasation—Paclitaxel—kidney cancer	0.0118	0.0118	CcSEcCtD
Telavancin—Hyponatraemia—Sorafenib—kidney cancer	0.0116	0.0116	CcSEcCtD
Telavancin—Hyponatraemia—Sunitinib—kidney cancer	0.0112	0.0112	CcSEcCtD
Telavancin—Venous thrombosis—Doxorubicin—kidney cancer	0.0101	0.0101	CcSEcCtD
Telavancin—Flatulence—Pazopanib—kidney cancer	0.01	0.01	CcSEcCtD
Telavancin—Abdominal discomfort—Sorafenib—kidney cancer	0.00958	0.00958	CcSEcCtD
Telavancin—Hyponatraemia—Vincristine—kidney cancer	0.00945	0.00945	CcSEcCtD
Telavancin—Abdominal discomfort—Sunitinib—kidney cancer	0.00922	0.00922	CcSEcCtD
Telavancin—Ulcer—Capecitabine—kidney cancer	0.00894	0.00894	CcSEcCtD
Telavancin—Infection—Temsirolimus—kidney cancer	0.00875	0.00875	CcSEcCtD
Telavancin—Phlebitis—Paclitaxel—kidney cancer	0.00868	0.00868	CcSEcCtD
Telavancin—Infection—Pazopanib—kidney cancer	0.00824	0.00824	CcSEcCtD
Telavancin—Flatulence—Everolimus—kidney cancer	0.00791	0.00791	CcSEcCtD
Telavancin—Flatulence—Erlotinib—kidney cancer	0.00763	0.00763	CcSEcCtD
Telavancin—Hyponatraemia—Paclitaxel—kidney cancer	0.00751	0.00751	CcSEcCtD
Telavancin—Phlebitis—Capecitabine—kidney cancer	0.00712	0.00712	CcSEcCtD
Telavancin—Body temperature increased—Temsirolimus—kidney cancer	0.00696	0.00696	CcSEcCtD
Telavancin—Necrosis—Doxorubicin—kidney cancer	0.00694	0.00694	CcSEcCtD
Telavancin—Abscess—Doxorubicin—kidney cancer	0.00689	0.00689	CcSEcCtD
Telavancin—Flatulence—Sunitinib—kidney cancer	0.0066	0.0066	CcSEcCtD
Telavancin—Infection—Everolimus—kidney cancer	0.00651	0.00651	CcSEcCtD
Telavancin—Infection—Erlotinib—kidney cancer	0.00628	0.00628	CcSEcCtD
Telavancin—Extravasation—Doxorubicin—kidney cancer	0.00624	0.00624	CcSEcCtD
Telavancin—Hyponatraemia—Capecitabine—kidney cancer	0.00616	0.00616	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.00614	0.00614	CcSEcCtD
Telavancin—Diarrhoea—Temsirolimus—kidney cancer	0.00602	0.00602	CcSEcCtD
Telavancin—Ulcer—Doxorubicin—kidney cancer	0.00576	0.00576	CcSEcCtD
Telavancin—Diarrhoea—Pazopanib—kidney cancer	0.00568	0.00568	CcSEcCtD
Telavancin—Infection—Sorafenib—kidney cancer	0.00565	0.00565	CcSEcCtD
Telavancin—Vomiting—Temsirolimus—kidney cancer	0.0056	0.0056	CcSEcCtD
Telavancin—Rash—Temsirolimus—kidney cancer	0.00555	0.00555	CcSEcCtD
Telavancin—Dermatitis—Temsirolimus—kidney cancer	0.00555	0.00555	CcSEcCtD
Telavancin—Infection—Sunitinib—kidney cancer	0.00543	0.00543	CcSEcCtD
Telavancin—Hyperkalaemia—Doxorubicin—kidney cancer	0.00535	0.00535	CcSEcCtD
Telavancin—Vomiting—Pazopanib—kidney cancer	0.00527	0.00527	CcSEcCtD
Telavancin—Rash—Pazopanib—kidney cancer	0.00523	0.00523	CcSEcCtD
Telavancin—Nausea—Temsirolimus—kidney cancer	0.00523	0.00523	CcSEcCtD
Telavancin—Dermatitis—Pazopanib—kidney cancer	0.00522	0.00522	CcSEcCtD
Telavancin—Body temperature increased—Everolimus—kidney cancer	0.00518	0.00518	CcSEcCtD
Telavancin—Infection—Dactinomycin—kidney cancer	0.00514	0.00514	CcSEcCtD
Telavancin—Abdominal discomfort—Capecitabine—kidney cancer	0.00508	0.00508	CcSEcCtD
Telavancin—Body temperature increased—Erlotinib—kidney cancer	0.005	0.005	CcSEcCtD
Telavancin—Nausea—Pazopanib—kidney cancer	0.00493	0.00493	CcSEcCtD
Telavancin—Infection—Vincristine—kidney cancer	0.0046	0.0046	CcSEcCtD
Telavancin—Phlebitis—Doxorubicin—kidney cancer	0.00459	0.00459	CcSEcCtD
Telavancin—Diarrhoea—Vinblastine—kidney cancer	0.0045	0.0045	CcSEcCtD
Telavancin—Body temperature increased—Sorafenib—kidney cancer	0.00449	0.00449	CcSEcCtD
Telavancin—Diarrhoea—Everolimus—kidney cancer	0.00448	0.00448	CcSEcCtD
Telavancin—Flatulence—Paclitaxel—kidney cancer	0.00444	0.00444	CcSEcCtD
Telavancin—Infection—Gemcitabine—kidney cancer	0.00436	0.00436	CcSEcCtD
Telavancin—Body temperature increased—Sunitinib—kidney cancer	0.00432	0.00432	CcSEcCtD
Telavancin—Diarrhoea—Erlotinib—kidney cancer	0.00432	0.00432	CcSEcCtD
Telavancin—Vomiting—Vinblastine—kidney cancer	0.00418	0.00418	CcSEcCtD
Telavancin—Vomiting—Everolimus—kidney cancer	0.00416	0.00416	CcSEcCtD
Telavancin—Rash—Everolimus—kidney cancer	0.00413	0.00413	CcSEcCtD
Telavancin—Dermatitis—Everolimus—kidney cancer	0.00413	0.00413	CcSEcCtD
Telavancin—Body temperature increased—Dactinomycin—kidney cancer	0.00409	0.00409	CcSEcCtD
Telavancin—Vomiting—Erlotinib—kidney cancer	0.00402	0.00402	CcSEcCtD
Telavancin—Rash—Erlotinib—kidney cancer	0.00398	0.00398	CcSEcCtD
Telavancin—Dermatitis—Erlotinib—kidney cancer	0.00398	0.00398	CcSEcCtD
Telavancin—Hyponatraemia—Doxorubicin—kidney cancer	0.00397	0.00397	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.00396	0.00396	CcSEcCtD
Telavancin—Nausea—Vinblastine—kidney cancer	0.00391	0.00391	CcSEcCtD
Telavancin—Nausea—Everolimus—kidney cancer	0.00389	0.00389	CcSEcCtD
Telavancin—Diarrhoea—Sorafenib—kidney cancer	0.00389	0.00389	CcSEcCtD
Telavancin—Nausea—Erlotinib—kidney cancer	0.00375	0.00375	CcSEcCtD
Telavancin—Diarrhoea—Sunitinib—kidney cancer	0.00374	0.00374	CcSEcCtD
Telavancin—Body temperature increased—Vincristine—kidney cancer	0.00366	0.00366	CcSEcCtD
Telavancin—Infection—Paclitaxel—kidney cancer	0.00365	0.00365	CcSEcCtD
Telavancin—Flatulence—Capecitabine—kidney cancer	0.00364	0.00364	CcSEcCtD
Telavancin—Vomiting—Sorafenib—kidney cancer	0.00361	0.00361	CcSEcCtD
Telavancin—Rash—Sorafenib—kidney cancer	0.00358	0.00358	CcSEcCtD
Telavancin—Dermatitis—Sorafenib—kidney cancer	0.00358	0.00358	CcSEcCtD
Telavancin—Diarrhoea—Dactinomycin—kidney cancer	0.00354	0.00354	CcSEcCtD
Telavancin—Vomiting—Sunitinib—kidney cancer	0.00348	0.00348	CcSEcCtD
Telavancin—Body temperature increased—Gemcitabine—kidney cancer	0.00347	0.00347	CcSEcCtD
Telavancin—Rash—Sunitinib—kidney cancer	0.00345	0.00345	CcSEcCtD
Telavancin—Dermatitis—Sunitinib—kidney cancer	0.00345	0.00345	CcSEcCtD
Telavancin—Nausea—Sorafenib—kidney cancer	0.00338	0.00338	CcSEcCtD
Telavancin—Vomiting—Dactinomycin—kidney cancer	0.00329	0.00329	CcSEcCtD
Telavancin—Rash—Dactinomycin—kidney cancer	0.00327	0.00327	CcSEcCtD
Telavancin—Nausea—Sunitinib—kidney cancer	0.00325	0.00325	CcSEcCtD
Telavancin—Diarrhoea—Vincristine—kidney cancer	0.00317	0.00317	CcSEcCtD
Telavancin—Nausea—Dactinomycin—kidney cancer	0.00308	0.00308	CcSEcCtD
Telavancin—Diarrhoea—Gemcitabine—kidney cancer	0.003	0.003	CcSEcCtD
Telavancin—Infection—Capecitabine—kidney cancer	0.003	0.003	CcSEcCtD
Telavancin—Vomiting—Vincristine—kidney cancer	0.00294	0.00294	CcSEcCtD
Telavancin—Rash—Vincristine—kidney cancer	0.00292	0.00292	CcSEcCtD
Telavancin—Dermatitis—Vincristine—kidney cancer	0.00291	0.00291	CcSEcCtD
Telavancin—Body temperature increased—Paclitaxel—kidney cancer	0.00291	0.00291	CcSEcCtD
Telavancin—Vomiting—Gemcitabine—kidney cancer	0.00279	0.00279	CcSEcCtD
Telavancin—Rash—Gemcitabine—kidney cancer	0.00277	0.00277	CcSEcCtD
Telavancin—Dermatitis—Gemcitabine—kidney cancer	0.00276	0.00276	CcSEcCtD
Telavancin—Nausea—Vincristine—kidney cancer	0.00275	0.00275	CcSEcCtD
Telavancin—Nausea—Gemcitabine—kidney cancer	0.00261	0.00261	CcSEcCtD
Telavancin—Diarrhoea—Paclitaxel—kidney cancer	0.00251	0.00251	CcSEcCtD
Telavancin—Body temperature increased—Capecitabine—kidney cancer	0.00238	0.00238	CcSEcCtD
Telavancin—Flatulence—Doxorubicin—kidney cancer	0.00235	0.00235	CcSEcCtD
Telavancin—Vomiting—Paclitaxel—kidney cancer	0.00234	0.00234	CcSEcCtD
Telavancin—Rash—Paclitaxel—kidney cancer	0.00232	0.00232	CcSEcCtD
Telavancin—Dermatitis—Paclitaxel—kidney cancer	0.00231	0.00231	CcSEcCtD
Telavancin—Nausea—Paclitaxel—kidney cancer	0.00218	0.00218	CcSEcCtD
Telavancin—Diarrhoea—Capecitabine—kidney cancer	0.00206	0.00206	CcSEcCtD
Telavancin—Infection—Doxorubicin—kidney cancer	0.00193	0.00193	CcSEcCtD
Telavancin—Vomiting—Capecitabine—kidney cancer	0.00192	0.00192	CcSEcCtD
Telavancin—Rash—Capecitabine—kidney cancer	0.0019	0.0019	CcSEcCtD
Telavancin—Dermatitis—Capecitabine—kidney cancer	0.0019	0.0019	CcSEcCtD
Telavancin—Nausea—Capecitabine—kidney cancer	0.00179	0.00179	CcSEcCtD
Telavancin—Body temperature increased—Doxorubicin—kidney cancer	0.00154	0.00154	CcSEcCtD
Telavancin—Diarrhoea—Doxorubicin—kidney cancer	0.00133	0.00133	CcSEcCtD
Telavancin—Vomiting—Doxorubicin—kidney cancer	0.00124	0.00124	CcSEcCtD
Telavancin—Rash—Doxorubicin—kidney cancer	0.00123	0.00123	CcSEcCtD
Telavancin—Dermatitis—Doxorubicin—kidney cancer	0.00122	0.00122	CcSEcCtD
Telavancin—Nausea—Doxorubicin—kidney cancer	0.00115	0.00115	CcSEcCtD
